Terms: = Leukemia AND PCSK7, Q16549, 9159, ENSG00000160613, PC8, SPC7, PC7, LPC AND Diagnosis
11 results:
1. Mass spectrometric discrimination of phospholipid patterns in cisplatin-resistant and -sensitive cancer cells.
Cadoni E; Vanhara P; Valletta E; Pinna E; Vascellari S; Caddeo G; Isaia F; Pani A; Havel J; Pivetta T
Rapid Commun Mass Spectrom; 2019 Jan; 33(1):97-106. PubMed ID: 30376198
[TBL] [Abstract] [Full Text] [Related]
2. Clonal selection and asymmetric distribution of human leukemia in murine xenografts revealed by cellular barcoding.
Belderbos ME; Koster T; Ausema B; Jacobs S; Sowdagar S; Zwart E; de Bont E; de Haan G; Bystrykh LV
Blood; 2017 Jun; 129(24):3210-3220. PubMed ID: 28396495
[TBL] [Abstract] [Full Text] [Related]
3. The significance of peripheral blood minimal residual disease to predict early disease response in patients with B-cell acute lymphoblastic leukemia.
Setiadi A; Owen D; Tsang A; Milner R; Vercauteren S
Int J Lab Hematol; 2016 Oct; 38(5):527-34. PubMed ID: 27339737
[TBL] [Abstract] [Full Text] [Related]
4. Immunophenotyping of selected hematologic disorders--focus on lymphoproliferative disorders with more than one malignant cell population.
Porwit A
Int J Lab Hematol; 2013 Jun; 35(3):275-82. PubMed ID: 23590655
[TBL] [Abstract] [Full Text] [Related]
5. Impact of malignant stem cell burden on therapy outcome in newly diagnosed chronic myeloid leukemia patients.
Mustjoki S; Richter J; Barbany G; Ehrencrona H; Fioretos T; Gedde-Dahl T; Gjertsen BT; Hovland R; Hernesniemi S; Josefsen D; Koskenvesa P; Dybedal I; Markevärn B; Olofsson T; Olsson-Strömberg U; Rapakko K; Thunberg S; Stenke L; Simonsson B; Porkka K; Hjorth-Hansen H;
Leukemia; 2013 Jul; 27(7):1520-6. PubMed ID: 23328954
[TBL] [Abstract] [Full Text] [Related]
6. Chemotherapy-related changes in central nervous system phospholipids and neurocognitive function in childhood acute lymphoblastic leukemia.
Krull KR; Hockenberry MJ; Miketova P; Carey M; Moore IM
Leuk Lymphoma; 2013 Mar; 54(3):535-40. PubMed ID: 22856670
[TBL] [Abstract] [Full Text] [Related]
7. Application of 31P MRS to the analysis of phospholipid changes in plasma of patients with acute leukemia.
Kuliszkiewicz-Janus M; Tuz MA; Baczyński S
Biochim Biophys Acta; 2005 Oct; 1737(1):11-5. PubMed ID: 16213190
[TBL] [Abstract] [Full Text] [Related]
8. Paucity of leukemic progenitor cells in the bone marrow of pediatric B-lineage acute lymphoblastic leukemia patients with an isolated extramedullary first relapse.
Uckun FM; Gaynon PS; Stram DO; Sensel MG; Sarquis MB; Lazarus KH; Willoughby M
Clin Cancer Res; 1999 Sep; 5(9):2415-20. PubMed ID: 10499612
[TBL] [Abstract] [Full Text] [Related]
9. Application of 31P NMR spectroscopy in clinical analysis of changes of serum phospholipids in leukemia, lymphoma and some other non-haematological cancers.
Kuliszkiewicz-Janus M; Janus W; Baczyński S
Anticancer Res; 1996; 16(3B):1587-94. PubMed ID: 8694531
[TBL] [Abstract] [Full Text] [Related]
10. Radiation resistance of primary clonogenic blasts from children with acute lymphoblastic leukemia.
Uckun FM; Aeppli D; Song CW
Int J Radiat Oncol Biol Phys; 1993 Nov; 27(4):899-906. PubMed ID: 8244821
[TBL] [Abstract] [Full Text] [Related]
11. Lack of CD24 antigen expression in B-lineage acute lymphoblastic leukemia is associated with intrinsic radiation resistance of primary clonogenic blasts.
Uckun FM; Song CW
Blood; 1993 Mar; 81(5):1323-32. PubMed ID: 8443393
[TBL] [Abstract] [Full Text] [Related]
